Oral Health Group

Dentsply Sirona Appoints Cherée Johnson as General Counsel and Executive Leadership Team Member

December 16, 2021
by Dentsply Sirona

Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, today announced the appointment of Cherée H. Johnson as SVP, Chief Legal Officer, General Counsel & Secretary. She will also become a member of the Executive Leadership Team and report directly to Don Casey, Chief Executive Officer.

Cherée H. Johnson will join Dentsply Sirona on February 28th, 2022 as its Senior Vice President, Chief Legal Officer, General Counsel and Secretary, and will be based at the Company’s headquarters in Charlotte, NC. She succeeds Keith J. Ebling who is leaving the Company in connection with the relocation of his position to Charlotte, NC and will help to ensure a smooth leadership transition.

“As a sophisticated, global lawyer, Cherée has deep legal experience and brings significant expertise in important areas, like ESG and M&A to Dentsply Sirona. She has an impressive leadership track record and a tremendous dedication to the customer perspective. We are very excited and fortunate to welcome her to the Dentsply Sirona team,” said Don Casey, CEO of Dentsply Sirona.

Cherée’s background spans across multiple industries and global operations. She brings tremendous strengths in ESG, compliance, M&A and financial transactions, enterprise risk management, capital markets and securities matters. Currently, she serves as Senior Vice President, General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer at W.R. Grace, a Standard Industries Company, with global operations. Before joining W.R. Grace, she served as Vice President, Deputy General Counsel and Assistant Corporate Secretary at McCormick & Company, H.J. Heinz Company and Cargill. She held a similar role at 3M Company, where she began her legal career. Cherée Johnson also worked at 3M as a product development lead and chemical engineer. She earned her law degree from University of Minnesota Law School and her undergraduate degree in Chemical Engineering from Florida A&M University. Cherée Johnson currently serves as a member of the Advisory Board of the Johns Hopkins Bloomberg School of Public Health and is a board member of several nonprofit organizations.

ABOUT DENTSPLY SIRONA                                                                                   

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.


This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as “may,” “could,” “estimate,” “will,” “believe,” “anticipate,” “think,” “intend,” “expect,” “project,” “plan,” “target,” “forecast”, and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.